Barriers and motivators to national board certification as a certified anticoagulation care provider Kelly M. RuddLynn B. OertelJennifer Palmer BriefCommunication 07 February 2022 Pages: 761 - 765
Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study Steve DeitelzweigXuemei LuoGregory Piazza OriginalPaper Open access 30 April 2022 Pages: 766 - 776
Development and validation of an analytical method for the determination of direct oral anticoagulants (DOAC) and the direct thrombin-inhibitor argatroban by HPLC–MS/MS Lea BrücknerJan Beyer-WestendorfJörg Pietsch OriginalPaper Open access 11 November 2021 Pages: 777 - 787
Complement system component dysregulation is a distinctive feature of COVID-19 disease: a prospective and comparative analysis of patients admitted to the emergency department for suspected COVID-19 disease Nadine GauchelMarina RiederLukas A. Heger OriginalPaper Open access 14 December 2021 Pages: 788 - 797
A systematic review of vaccine-induced thrombotic thrombocytopenia in individuals who received COVID-19 adenoviral-vector-based vaccines Mostafa H. ElberryHussien Ahmed H. AbdelgawadAhmed Negida ReviewPaper Open access 14 February 2022 Pages: 798 - 823
Characteristics and comparisons of acute stroke in “recovered" to “active COVID-19 and “pre-pandemic” in Qatar database Naveed AkhtarFatma AbidAshfaq Shuaib ReviewPaper Open access 04 March 2022 Pages: 824 - 828
Ventilation/perfusion (V/Q) scanning in contemporary patients with pulmonary embolism: utilization rates and predictors of use in a multinational study Pierre-Benoît BonnefoyNathalie PrevotAnd RIETE investigators OriginalPaper 05 October 2021 Pages: 829 - 840
Novel multi-marker proteomics in phenotypically matched patients with ST-segment myocardial infarction: association with clinical outcomes Jay S. ShavadiaWendimagegn AlemayehuSean van Diepen OriginalPaper 27 October 2021 Pages: 841 - 850
Oral anticoagulation patterns and prognosis in octogenarian patients with atrial fibrillation Anastasios PapanastasiouAnastasios KartasGeorge Giannakoulas OriginalPaper 25 September 2021 Pages: 851 - 860
Incidence of thrombotic complications related to weight-based dosing of activated prothrombin complex concentrate (aPCC) for reversal of apixaban and rivaroxaban in obese patients Caitlyn WhitakerAmanda McKinneyA. Shaun Rowe OriginalPaper 17 November 2021 Pages: 861 - 867
Antithrombotic strategy and its relationship with outcomes in patients with atrial fibrillation and chronic coronary syndrome Wen-He LvJian-Zeng DongChang-Sheng Ma OriginalPaper 22 October 2021 Pages: 868 - 877
An abbreviated Caprini model for VTE risk assessment in trauma Max D. HazeltineErin M. ScottJon D. Dorfman OriginalPaper 20 November 2021 Pages: 878 - 886
Association of acidosis with coagulopathy and transfusion requirements in liver transplantation Júlia Ruete de SouzaAna Paula YokoyamaFernanda Andrade Orsi OriginalPaper 20 November 2021 Pages: 887 - 897
Efficacy outcomes and safety measures of intravenous tirofiban or eptifibatide for patients with acute ischemic stroke: a systematic review and meta-analysis of prospective studies Jingting LiuYihong YangHongbo Liu ReviewPaper 15 November 2021 Pages: 898 - 910
Different patterns of white matter lesions among patent foramen ovale, atherosclerotic cerebral small vessel disease and cerebral venous thrombosis Xiaoqin WuKara KlomparensRan Meng OriginalPaper 05 January 2022 Pages: 911 - 925
The long-term survival in patients with chronic thromboembolic pulmonary hypertension: experience from a single center in China Song HuJiang-Shan TanLu Hua OriginalPaper 27 October 2021 Pages: 926 - 933
Italian experience with rVIII-single chain: a survey of patients with haemophilia A and their physicians Alessandra BorchielliniGiancarlo CastamanEzio Zanon OriginalPaper Open access 13 November 2021 Pages: 934 - 944
Concomitant factor VIII inhibitor and lupus anticoagulant in an asymptomatic patient Jeremy W. JacobsSavanah D. GisrielHenry M. Rinder BriefCommunication 25 October 2021 Pages: 945 - 949
Initial assessment of α-synuclein structure in platelets Catherine M. StefaniukJune SchlegelmilchRobert W. Maitta BriefCommunication 19 November 2021 Pages: 950 - 953
Eltrombopag for refractory vaccine-induced immune thrombotic thrombocytopenia Giorgio MarazitiCecilia Becattini BriefCommunication 19 November 2021 Pages: 954 - 958
Evaluation of heparin infusion rates in patients with intravenous drug misuse Kenneth BargaAdam SmithKatherine Crawford OriginalPaper 22 November 2021 Pages: 959 - 964
Thrombosis in VEXAS syndrome Thet Mon OoJie Tian Jeanette KoayBingwen Eugene Fan BriefCommunication 24 November 2021 Pages: 965 - 970
Thromboembolic events following mRNA vaccines for COVID 19: a case series Alessandra SerraoRoberta AgrippinoAntonio Chistolini Letter to the Editor 03 February 2022 Pages: 971 - 973
REPLY to “Association Between Plasmatic Oxidative Stress and Thrombosis in Primary Antiphospholipid Syndrome” T. BucciD. PastoriP. R. J. Ames Letter to the Editor 30 January 2022 Pages: 974 - 975
Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study—Reply to comment from Muzaffar et al. Bingwen Eugene FanYew Woon ChiaShiun Woei Wong Letter to the Editor 03 February 2022 Pages: 976 - 978